Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin
Open Access
- 9 November 2023
- journal article
- case report
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (22) , 16109
Abstract
Penile squamous cell carcinoma is a rare disease with very limited data to guide treatment decisions. In particular, there is minimal evidence for effective therapies in the metastatic setting. Here, we present a case of metastatic penile squamous cell carcinoma with response to the Nectin-4 inhibitor enfortumab-vedotin-ejfv (EV). EV was selected due to the evidence of the high expression of Nectin-4 in squamous cell carcinomas, including penile carcinoma. The patient had both radiographic and symptomatic improvement after two cycles of treatment, despite having been treated with multiple prior lines of traditional chemotherapy. This case provides support for the use of antibody–drug conjugates (ADC), including EV, in this disease with few other options in the advanced setting. Further studies examining Nectin-4 and ADCs in penile squamous cell carcinoma should be completed, as high-quality evidence is needed to guide treatment after initial progression for these patients.Keywords
Funding Information
- National Cancer Institute (F32CA254070, T32CA217834, K12CA090625, P30CA068485, S10 OD023475-01A1, S10 OD016355)
- NCI/NIH Cancer Center Support (F32CA254070, T32CA217834, K12CA090625, P30CA068485, S10 OD023475-01A1, S10 OD016355)
This publication has 41 references indexed in Scilit:
- Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancerJournal of Experimental & Clinical Cancer Research, 2015
- Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinomaBJU International, 2015
- Epidermal growth factor receptor‐targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penisBJU International, 2013
- Cisplatin and 5‐fluorouracil in inoperable, stage IV squamous cell carcinoma of the penisBJU International, 2012
- Treatment of Visceral, Unresectable, or Bulky/Unresectable Regional Metastases of Penile CancerUrology, 2010
- Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung CancerCancer Research, 2009
- Cisplatin and gemcitabine in the management of metastatic penile cancerUrologic Oncology: Seminars and Original Investigations, 2009
- Penile cancer: epidemiology, pathogenesis and preventionWorld Journal of Urology, 2008
- Erratum: Development of potent monoclonal antibody auristatin conjugates for cancer therapyNature Biotechnology, 2003
- Development of potent monoclonal antibody auristatin conjugates for cancer therapyNature Biotechnology, 2003